Home » FDA Panel Votes to Recommend More Restrictions on Hydrocodone Combos
FDA Panel Votes to Recommend More Restrictions on Hydrocodone Combos
An FDA advisory panel voted 19–10 Friday to recommend up-scheduling hydrocodone combination products to schedule II controlled substances, a move that would bring tighter restrictions on the opioid painkillers.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May